Carla Benedito, general manager of Shire Portugal, provides useful insight into the rare diseases landscape in Portugal. Carla discusses market access models for innovative and rare treatments, encouraging dialogue between industry and government, and the touching nature of working for a pharmaceutical company that knows all of its patients by name.
How is the Shire global portfolio reflected in Portugal?
"We are cautiously optimistic and hopeful that the new legislation will be a game-changer for Portugal, shifting the paradigm for patient care. "
